Christine Garrett
Corporate Officer/Principal bei LEO Pharma A/S
Aktive Positionen von Christine Garrett
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
LEO Pharma A/S
LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | Corporate Officer/Principal | - | - |
Karriereverlauf von Christine Garrett
Ehemalige bekannte Positionen von Christine Garrett
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - | - |
LENZ THERAPEUTICS, INC. | Geschäftsführer | 01.01.2022 | - |
Personalreferent | 01.01.2022 | - | |
Public Communications Contact | - | - |
Ausbildung von Christine Garrett
Rochester Institute of Technology | Undergraduate Degree |
Massachusetts Institute of Technology | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 5 |
Dänemark | 2 |
Operativ
Corporate Officer/Principal | 2 |
Chief Operating Officer | 1 |
Human Resources Officer | 1 |
Sektoral
Health Technology | 4 |
Consumer Services | 2 |
Finance | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
Private Unternehmen | 2 |
---|---|
LEO Pharma A/S
LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | Health Technology |
Graphite Bio, Inc.
Graphite Bio, Inc. BiotechnologyHealth Technology Graphite Bio, Inc. is a clinical-stage gene editing company. It engages in the business of developing therapies that harness targeted gene integration to treat or cure serious diseases. The company was founded by Matthew Porteus and Maria Grazia Roncarolo on June 1, 2017 and is headquartered in South San Francisco, CA. | Health Technology |
- Börse
- Insiders
- Christine Garrett
- Erfahrung